Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
Yunxing Shi, Yi Niu, Yichuan Yuan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application
Na Liu, Min‐Bin Chen
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116115-116115
Open Access | Times Cited: 45
Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC
Yau-Tuen Chan, Junyu Wu, Yuanjun Lu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 22
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 21
Doxorubicin prodrug for γ-glutamyl transpeptidase imaging and on-demand cancer therapy
Yanhua Li, Jiexiang Zhao, Kun Tang, et al.
Biosensors and Bioelectronics (2025) Vol. 272, pp. 117127-117127
Closed Access | Times Cited: 1
PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer
Jiaoti Huang, Bei-Ning Qiao, Yixin Yuan, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 4
Open Access | Times Cited: 1
Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance
Yihang Gao, Chongchong Feng, Jingru Ma, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116048-116048
Closed Access | Times Cited: 8
Charge-reversal biodegradable nanoplatform with ferroptosis and ICD induction for tumor synergistic treatment
Ping Sun, Li Huang, Zimu Li, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149234-149234
Closed Access | Times Cited: 6
Crosstalk between m6A modification and non-coding RNAs in HCC
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 6
PRMT3 methylates HIF-1α to enhance the vascular calcification induced by chronic kidney disease
Guangyu Zhou, Chen Zhang, Hui Peng, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 5
Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Yunxing Shi, Zongfeng Wu, Shaoru Liu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Deficiency of betaine-homocysteine methyltransferase activates glucose-6-phosphate dehydrogenase (G6PD) by decreasing arginine methylation of G6PD in hepatocellular carcinogenesis
Jie Gao, Xiaoyi Shi, Yaohui Sun, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 8, pp. 1648-1665
Closed Access | Times Cited: 4
Histone lactylation drives liver cancer metastasis by facilitating NSF1-mediated ferroptosis resistance after microwave ablation
Jiayan Huang, Huijing Xie, Ju Li, et al.
Redox Biology (2025) Vol. 81, pp. 103553-103553
Open Access
The biological roles and molecular mechanisms of m6A reader IGF2BP1 in the hallmarks of cancer
Qiu Li, Shourong Wu, Lei Zhang, et al.
Genes & Diseases (2025), pp. 101567-101567
Open Access
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
PADI4 facilitates stem‐like properties and cisplatin resistance through upregulating PRMT2/IDs family in oesophageal squamous cell carcinoma
Zeyu Wang, Hao Wu, Zhaoxing Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access
Increased keratin 80 expression predicts poor prognosis and promotes oxaliplatin resistance in gastric cancer
Bo Yang, Hongxia Cao, Yulong He, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 12
Closed Access
KLX ameliorates liver cancer progression by mediating ZBP1 transcription and ubiquitination and increasing ZBP1-induced PANoptosis
Zhuo Wang, Yang Yang, Fangyin Yao, et al.
Acta Pharmacologica Sinica (2025)
Open Access
ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance
Jianing Tang, Guo Long, Desheng Xiao, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 10
Citrullinated IGF2BP1 promotes rheumatoid synovial aggression via increasing the mRNA stability of SEMA3D
Qin Yang, Li Liu, Yanwen Zhang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Targeting Wnt Signaling in Cancer Drug Resistance: Insights from Pre-Clinical and Clinical Research
Kiavash Hushmandi, Mina Alimohammadi, Mohammad Heiat, et al.
Pathology - Research and Practice (2025) Vol. 267, pp. 155837-155837
Closed Access
Development of Cytolytic Iridium-Complexed Octaarginine Peptide Albumin Nanomedicine for Hepatocellular Carcinoma Treatment
Xingwei Sun, Di Wang, Shiwei Chang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2395-2409
Open Access
PRMT3 drives PD-L1-mediated immune escape through activating PDHK1-regulated glycolysis in hepatocellular carcinoma
Chen‐Hong Ding, Fang‐Zhi Yan, Binghe Xu, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
PDZK1 inhibits MRP2-mediated oxaliplatin chemosensitivity in hepatocellular carcinoma
Zhenfeng Duan, Jinyu Li, Chao Ren, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
NEIL3 Deficiency Enhances HCC Cell Sensitivity to Oxaliplatin by Inhibiting the Fanconi Anaemia Pathway
J Wang, Chunhong Liao, Jing Luo, et al.
Cell Biology International (2025)
Closed Access
Asymmetric Dimethylarginine Disrupts Tumor Antigen Presentation in Breast Cancer
Mei Li, Yi-Ling Chen, Lynne Pearce, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4482-4482
Open Access
Page 1 - Next Page

Scroll to top